4D Molecular Therapeutics, Inc. (FDMT)
Nasdaq: FDMT · Biological Products, (No Diagnostic Substances) · Emeryville, CA · filing with the SEC since 2015
Who owns 4D Molecular Therapeutics, Inc.
As filed with the SECHolders of 5% or more
7
Janus Henderson Group PLC holds 10.3% of Common Stock, as its SCHEDULE 13G/A filed Apr 7, 2026 says.
Directors and officers
12
report now, of 22 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 7 named at left.
Holders of 5% or moreshare of the class, as filed
Janus Henderson Group PLC
SCHEDULE 13G/A · filed Apr 7, 2026 · Common Stock · 8.1% in Feb 17, 2026
Bvf Partners L P/il
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.0001 per share · 9.99% in Feb 17, 2026
RA Capital Management, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.0001 par value per share · 9.9% in Feb 17, 2026
Goldman Sachs Group Inc.
SCHEDULE 13G/A · filed Feb 9, 2026 · Common Stock, par value $0.0001 per share · 9.6% in Feb 10, 2025
Blackrock, Inc.
SCHEDULE 13G/A · filed Oct 17, 2025 · Common Stock · 7.8% in Apr 17, 2025
Novo Holdings A/S
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par value $0.0001 per share · 6.8% in Oct 20, 2025
State Street Corporation
SCHEDULE 13G · filed May 12, 2026 · COMMON STOCK
Venrock Healthcare Capital Partners III, L.P.
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 6.4% in Feb 14, 2025
Deep Track Capital, LP
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%
What FDMT reports owning in othersstakes of 5% or more, and other ties
4D Molecular Therapeutics, Inc. reports no stake in another company in the record.
Insider tradesForm 4
26sales
0purchases
22sales on a scheduled plan
3people selling
$5.4Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 20, 2025 to Oct 20, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 20, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 42 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Kirn David | See Remarks | 12 | $5.0M | 12 | 0 | $0 |
| Bizily Scott | Chief Legal Officer | 10 | $400,000 | 10 | 0 | $0 |
| Gupta Ashoo | VP, Finance and Controller | 4 | $0 | 0 | 0 | $0 |